Skymab presented the latest advances of its next-generation ADC platform at World ADC London 2026, highlighting progress toward IND-enabling studies for SKM104 and the continued expansion of the SKYLINK™ technology platform.
The conference provided valuable opportunities to engage with global pharmaceutical partners and the international ADC community.